Skip to main content

D. E. Shaw & Co., Inc.

Position in NEO — Neogenomics Inc

CIK 1009207 New York, NY

Position in NEO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$32,021,518
+$1,123,281 QoQ
Shares Held
2,194,758
-47.3% QoQ
Ownership
1.71%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#19
of 266 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in NEO Over Time

Shares Held

Position Value (USD)

Derivatives in NEO

reported options exposure · as of Mar 31, 2022
CallValue
$0
CallShares
0
PutValue
$364,500
PutShares
30,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $2,165,536,060 across 26 Diagnostics & Research names. NEO ranks #12 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NEO

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $32,021,518 2,194,758
2026-03-31 $30,898,237 4,164,183
2025-12-31 $62,298,929 5,297,528
2025-09-30 $25,455,966 3,297,405
2025-06-30 $6,836,136 935,176
2024-12-31 $657,700 39,909
2024-09-30 $880,988 59,728
2024-06-30 $2,310,131 166,556
2024-03-31 $2,283,927 145,288
2023-12-31 $6,377,816 394,179
2023-09-30 $9,550,482 776,462
2023-06-30 $14,365,856 893,955
2023-03-31 $14,345,508 823,981
2022-12-31 $9,130,773 988,179
2022-09-30 $5,451,860 633,201
2022-06-30 $8,224,050 1,009,086
2022-03-31 $364,500 30,000
2022-03-31 $355,982 29,299
2021-09-30 $1,206,000 25,000
2021-06-30 $1,129,250 25,000
2021-03-31 $458,040 9,497
2020-12-31 $1,584,834 29,436
2020-06-30 $313,517 10,120